Clinical Trials and Research News Weekly Roundup | S2 E27 | WHO and Ivermectin

TrialSite News Weekly Roundup

WHO & Pan American Health Organization Position on Ivermectin Use & COVID-19: Produce Evidence via RCT

In recent episodes, we’ve covered a plethora of stories about Ivermectin from around the globe. Recently, the Pan American Health Organization (PAHO) and the WHO (World Health Organization) came together to respond to the growing use of Ivermectin (especially in South America) to treat COVID-19. Although the “Monash” study demonstrated successfully that Ivermectin could be used to treat SARS-CoV-2 in experimentally infected cells and two preprint publications, based on observational studies reporting the apparent utility of Ivermectin to treat patients with COVID-19 needing mechanical ventilation, none of these sources represent sufficient evidence justifying use of the drug off label. The observational studies were not accepted in any peer reviewed journals and one of them was associated with the suspect “Surgisphere” group. Which we discussed at length in our Watchlist Episode titled: Hydroxychloroquine and the Mysteries Surgisphere Database. Consequently, PAHO and WHO recommend the only Ivermectin use occur in randomized controlled tri...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee